Abstract:This review focusses on sudden unexpected death in epilepsy patients (SUDEP) and incorporates risk stratification (through SUDEP risk factors and SUDEP risk scores), hypotheses on the mechanism of SUDEP and eligible seizure detection devices (SDDs) for further SUDEP prevention studies. The main risk factors for SUDEP are the presence and the frequency of generalized tonic-clonic seizures (GTC). In Swedish population-based case control study, the Odds ratio of the presence of GTC in the absence of bedroom sharing is 67. SUDEP risk scoring systems express a score that represents the cumulative presence of SUDEP risk factors, but not the exact effect of their combination. We describe 4 of the available scoring systems: SUDEP-7 inventory, SUDEP-3 inventory, SUDEP-ClinicAl Risk scorE (SUDEP-CARE score) and Kempenhaeghe SUDEP risk score. Although they all include GTC, their design is often different. Three of 4 scoring systems were validated (SUDEP-7 inventory, SUDEP-3 inventory and SUDEP-CARE score). None of the available scoring systems has been sufficiently validated for the use in a general epilepsy population. Plausible mechanisms of SUDEP are discussed. In the MORTEMUS-study (Mortality in Epilepsy Monitoring Unit Study), SUDEP was a postictal cardiorespiratory arrest after a GTC. The parallel respiratory and cardiac dysfunction in SUDEP suggests a central dysfunction of the brainstem centers that are involved in the control of respiration and heart rhythm. In the (consequent) adenosine serotonin hypotheses SUDEP occurs when a postictal adenosine-mediated respiratory depression is not compensated by the effect of serotonin. Other (adjuvant) mechanisms and factors are discussed. Seizure detection devices (SDDs) may help to improve nocturnal supervision. Five SDDs have been validated in phase 3 studies for the detection of TC: Seizure Link®, Epi-Care®, NightWatch, Empatica, Nelli®. They have demonstrated a sensitivity of at least 90 % combined with an acceptable false positive alarm rate. It has not yet been proven that the use will actually lead to SUDEP prevention, but clinical experience supports their effectiveness.

The research advance of risk factors and risk assessment of sudden unexpected death in epilepsy

Research progress of sudden unexpected death in epilepsy

Sudden Unexpected Death in Epilepsy:A Search for Incidence and Risk Factors

A New Rapid Acquisition Technique for Direct Sequence Spread-Spectrum Communications

The application of SUDEP in forensic diagnosis: a mini review

Analysis of forensic autopsy cases associated with epilepsy: Comparison between sudden unexpected death in epilepsy (SUDEP) and not-SUDEP groups

Sudden unexpected death in epilepsy: respiratory vs. cardiac contributions

For the 50th anniversary of the laboratory of alkaloid chemistry, Institute of the Chemistry of Plant Substances of the Uzbekistan Republic Academy of Sciences

Modulation of morphine analgesia by site-specific N-methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time

Incidence of Sudden Unexpected Death in Epilepsy in Community-Based Cohort in China

Challenges and future directions of SUDEP models

SUDEP, Suspected Positional Airway Obstruction, and Hypoventilation in Postictal Coma

The Incidence of Peri-Ictal Prone Position in Patients with Generalized Convulsive Seizures

Seizures and Sudden Death Beyond SUDEP

Embolization of gastrointestinal hemorrhage.

Update review on SUDEP: Risk assessment, background & seizure detection devices

Summary of first round cluster analysis: complete antibody panel.

Natural products derived from unusual variants of the shikimate pathway.

Mortality of epilepsy in Chinese populations: a comprehensive review

Derivation and validation of a new prediction model for sudden unexpected death in epilepsy based on a longitudinal prospective population-based cohort

Proteomics and Transcriptomics of the Hippocampus and Cortex in SUDEP and High-Risk SUDEP Patients